184 related articles for article (PubMed ID: 24491803)
1. miR-28-5p promotes chromosomal instability in VHL-associated cancers by inhibiting Mad2 translation.
Hell MP; Thoma CR; Fankhauser N; Christinat Y; Weber TC; Krek W
Cancer Res; 2014 May; 74(9):2432-43. PubMed ID: 24491803
[TBL] [Abstract][Full Text] [Related]
2. Re: miR-28-5p promotes chromosomal instability in VHL-associated cancers by inhibiting Mad2 translation.
Atala A
J Urol; 2015 Feb; 193(2):730. PubMed ID: 25617309
[No Abstract] [Full Text] [Related]
3. VHL loss causes spindle misorientation and chromosome instability.
Thoma CR; Toso A; Gutbrodt KL; Reggi SP; Frew IJ; Schraml P; Hergovich A; Moch H; Meraldi P; Krek W
Nat Cell Biol; 2009 Aug; 11(8):994-1001. PubMed ID: 19620968
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor VHL functions in the control of mitotic fidelity.
Hell MP; Duda M; Weber TC; Moch H; Krek W
Cancer Res; 2014 May; 74(9):2422-31. PubMed ID: 24362914
[TBL] [Abstract][Full Text] [Related]
6. Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells' sensitivity to paclitaxel.
Tambe M; Pruikkonen S; Mäki-Jouppila J; Chen P; Elgaaen BV; Straume AH; Huhtinen K; Cárpen O; Lønning PE; Davidson B; Hautaniemi S; Kallio MJ
Oncotarget; 2016 Mar; 7(11):12267-85. PubMed ID: 26943585
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous reduction of MAD2 and BUBR1 expression induces mitotic spindle alterations associated with p53 dependent cell cycle arrest and death.
Lentini L; Piscitello D; Veneziano L; Di Leonardo A
Cell Biol Int; 2014 Aug; 38(8):933-41. PubMed ID: 24687487
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner.
Huang Q; Sun Y; Zhai W; Ma X; Shen D; Du S; You B; Niu Y; Huang CP; Zhang X; Chang C
Oncogene; 2020 Oct; 39(43):6677-6691. PubMed ID: 32943729
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.
Hirata H; Hinoda Y; Ueno K; Nakajima K; Ishii N; Dahiya R
Carcinogenesis; 2012 Mar; 33(3):501-8. PubMed ID: 22180573
[TBL] [Abstract][Full Text] [Related]
10. The Mad1-Mad2 balancing act--a damaged spindle checkpoint in chromosome instability and cancer.
Schuyler SC; Wu YF; Kuan VJ
J Cell Sci; 2012 Sep; 125(Pt 18):4197-206. PubMed ID: 23093575
[TBL] [Abstract][Full Text] [Related]
11. Pseudohypoxia induced by miR-126 deactivation promotes migration and therapeutic resistance in renal cell carcinoma.
Liu W; Chen H; Wong N; Haynes W; Baker CM; Wang X
Cancer Lett; 2017 May; 394():65-75. PubMed ID: 28257806
[TBL] [Abstract][Full Text] [Related]
12. VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma.
Mikhaylova O; Stratton Y; Hall D; Kellner E; Ehmer B; Drew AF; Gallo CA; Plas DR; Biesiada J; Meller J; Czyzyk-Krzeska MF
Cancer Cell; 2012 Apr; 21(4):532-46. PubMed ID: 22516261
[TBL] [Abstract][Full Text] [Related]
13. Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways.
Lichner Z; Mejia-Guerrero S; Ignacak M; Krizova A; Bao TT; Girgis AH; Youssef YM; Yousef GM
Am J Pathol; 2012 Apr; 180(4):1675-87. PubMed ID: 22326755
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB-dependent plasticity of the epithelial to mesenchymal transition induced by Von Hippel-Lindau inactivation in renal cell carcinomas.
Pantuck AJ; An J; Liu H; Rettig MB
Cancer Res; 2010 Jan; 70(2):752-61. PubMed ID: 20068166
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
Liu N; Xia WY; Liu SS; Chen HY; Sun L; Liu MY; Li LF; Lu HM; Fu YJ; Wang P; Wu H; Gao JX
Sci Rep; 2016 Feb; 6():20489. PubMed ID: 26841847
[TBL] [Abstract][Full Text] [Related]
16. Regulation of receptor for activated C kinase 1 protein by the von Hippel-Lindau tumor suppressor in IGF-I-induced renal carcinoma cell invasiveness.
He X; Wang J; Messing EM; Wu G
Oncogene; 2011 Feb; 30(5):535-47. PubMed ID: 20871634
[TBL] [Abstract][Full Text] [Related]
17. HNF1B Loss Exacerbates the Development of Chromophobe Renal Cell Carcinomas.
Sun M; Tong P; Kong W; Dong B; Huang Y; Park IY; Zhou L; Liu XD; Ding Z; Zhang X; Bai S; German P; Powell R; Wang Q; Tong X; Tannir NM; Matin SF; Rathmell WK; Fuller GN; McCutcheon IE; Walker CL; Wang J; Jonasch E
Cancer Res; 2017 Oct; 77(19):5313-5326. PubMed ID: 28807937
[TBL] [Abstract][Full Text] [Related]
18. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
19. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
